Alnylam Pharmaceuticals Inc. (ALNY)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 721,053 $175,215,879 1.09%
2. 500,000 $121,500,000 -40% 3.62%
3.
VenBio Select Advisor

Kurt Von Emster

400,000 $97,200,000 +34% 1.29%
4. 367,289 $89,251,227 +819% 0.01%
5.
Aequim Alternative InvestmentsNOTE 1.000% 9/1

Franklin Parlamis

80,000,000 $86,400,000 +129% 3.14%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$71.87 297,501 Large Shareholder 10,554,134 2017-05-31 Filing
$65.35 11,500 Officer 11,500 2017-05-30 Filing
$37.00 27,900 Director 27,900 2016-10-13 Filing
$58.36 2,000 Director 4,000 2016-03-09 Filing
$69.75 205,030 Large Shareholder 10,256,633 2016-02-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$280.00 15,000 Officer, Director 73,441 2024-08-20 Filing
$274.65 135 Officer 12,881 2024-08-12 Filing
$273.73 1,158 Officer 13,016 2024-08-12 Filing
$272.43 3,913 Officer 14,174 2024-08-12 Filing
$271.32 5,736 Officer 18,087 2024-08-12 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 16,174,563 $3,096,023,554 0.55%
2. 11,943,895 $2,286,180,943 0.05%
3. 10,312,356 $1,973,888,016 0.15%
4. 8,521,115 $1,631,026,620 0.04%
5. 7,214,198 $1,380,869,641 0.25%
News See All